Cellectar Biosciences Inc (NAS:CLRB)
$ 1.46 -0.06 (-3.95%) Market Cap: 60.25 Mil Enterprise Value: 42.59 Mil PE Ratio: 0 PB Ratio: 36.50 GF Score: 32/100

Cellectar Biosciences Inc KOL Call Transcript

Jan 19, 2024 / 01:30PM GMT
Release Date Price: $3.48 (-1.69%)
Operator

Good morning, and welcome to Cellectar Biosciences conference call with Dr. Yair Levy to discuss his perspective as the community-based hematologist on the top-line results of Cellectar's CLOVER-WaM pivotal study that was released last week, Monday. Today's call is being recorded.

Before we begin, I would like to remind everyone that statements made during this call relating to Cellectar's expected future performance, future business prospects, or future events or plans are forward-looking statements as defined under the Private Securities Litigation Reform Act of 1995.

Although the company believes that the expectations reflected in such forward-looking statements are based upon reasonable assumptions, actual outcomes and results are subject to risks and uncertainties that could differ materially from those forecast due to the impact of many factors beyond the control of Cellectar.

The company assumes no obligation to update or supplement any forward-looking statements, whether as a result of new information, future events, or otherwise. Participants are directed to the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot